Clinical Trials on Tuberous Sclerosis
Total 4510 results
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
Barnes Retina InstituteCompletedNuclear Sclerotic CataractUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingTuberous Sclerosis Complex | LymphangioleiomyomatosisUnited States
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
Bagcilar Training and Research HospitalCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)Uniformed Services University of the Health SciencesRecruiting
-
Marinus PharmaceuticalsCompletedTuberous SclerosisUnited States
-
Eunice Kennedy Shriver National Institute of Child...TerminatedTuberous Sclerosis | AutismUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
University of California, Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsUnknown
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
The University of Texas Health Science Center,...CompletedTuberous Sclerosis | AngiofibromasUnited States, Australia
-
Aucta Pharmaceuticals, IncTerminatedTuberous Sclerosis | Angiofibroma of FaceUnited States, China
-
UMC UtrechtBoehringer Ingelheim; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingSystemic Sclerosis | Scleroderma, Diffuse | Mycophenolate Mofetil | Scleroderma | Autologous Stem Cell Transplantation | Cyclophosphamide | Systemic Scleroses, Diffuse | Treatment StrategyItaly, Switzerland, Netherlands, Sweden, United Kingdom
-
National Taiwan University HospitalCompletedFacial Angiofibroma
-
ChemomAb Ltd.CompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC) | Systemic Sclerosis (SSc)Israel
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
University Hospital, BordeauxCompletedTuberous Sclerosis | Renal AngiomyolipomasFrance
-
Dermatology Specialties Limited PartnershipCompletedTuberous Sclerosis | Facial AngiofibromaUnited States, Taiwan, Serbia, Spain, Australia, Czechia, Hungary, New Zealand, Slovakia
-
CENTOGENE GmbH RostockTerminatedLymphangioleiomyomatosis | Subependymal Giant Cell Astrocytoma | Facial Angiofibroma | Cortical Dysplasia | Renal Angiomyolipoma | Hypomelanotic Macules | Shagreen Patches | Ungual Fibromas | Cardiac RhabdomyomaSri Lanka, Albania, Romania, Egypt, Pakistan, Georgia, India, Lithuania
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
University of PennsylvaniaH. Lundbeck A/STerminatedComplex Partial SeizuresUnited States
-
The University of Texas Health Science Center,...Society for Pediatric DermatologyCompletedTuberous Sclerosis | Neurofibromatoses | Neurofibroma | AngiofibromaUnited States
-
Imagine InstituteRWTH Aachen University; Ruhr University of Bochum; Medical University of WarsawRecruitingEpilepsy | Tuberous SclerosisFrance
-
National Tuberous Sclerosis AssociationRecruitingTuberous Sclerosis | LymphangioleiomyomatosisUnited States, Canada
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedTuberous Sclerosis | Lymphangioleiomyomatosis | LymphangioleiomyomasUnited States
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis | Subependymal Giant Cell AstrocytomaUnited States, Belgium, Canada, Germany, Italy, Russian Federation, Netherlands, Poland, Australia, United Kingdom
-
University of NottinghamCompletedTuberous Sclerosis | LymphangioleiomyomatosisUnited Kingdom
-
Cardiff UniversityWyeth is now a wholly owned subsidiary of Pfizer; University of Nottingham; Royal... and other collaboratorsUnknownTuberous Sclerosis | LymphangioleiomyomatosisUnited Kingdom
-
University of California, Los AngelesRecruitingTuberous SclerosisUnited States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Children's Hospital Medical Center, CincinnatiNovartisCompletedTuberous Sclerosis | AngiolipomaUnited States
-
InCor Heart InstituteNovartisCompletedTuberous Sclerosis | Angiomyolipoma | LymphangioleiomyomatosisBrazil
-
Children's Hospital Medical Center, CincinnatiNovartis PharmaceuticalsCompletedTuberous Sclerosis | LymphangioleiomyomatosisUnited States
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Universiteit AntwerpenUniversity Hospital, AntwerpRecruiting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Medical University of GrazRecruitingMorphea (Circumscribed Scleroderma) | Sclerotic Graft-versus-host Disease (GVHD)Austria
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States